Text Registration
Copyright Title
The Next Frontier: Therapeutic Advances in Relapsed/Refractory DLBCL
Status
Published
on 26 Apr 2021
Year of Creation
2021
Copyright Claimant
Med-IQ
Registration Number
TX0008965771
on 26 Apr 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008965771) dated 26 Apr 2021, pertains to an electronic file (eService) titled "The Next Frontier: Therapeutic Advances in Relapsed/Refractory DLBCL" created in 2021. The copyright holder is Med-IQ, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Med-IQ.
Application Details
Registration Number
TX0008965771
Registration Date
4/26/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Med-IQ
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Susan Dembeck, Med-IQ, 5523 Research Park Dr, Ste 210, Baltimore, MD, 21228, United States, (443) 543-5114, sdembeck@med-iq.com
Statements
Application Title Statement: The Next Frontier: Therapeutic Advances in Relapsed/Refractory DLBCL
Author Statement: Med-IQ employer for hire Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.